Meiqi Wang

1.8k total citations · 1 hit paper
90 papers, 1.2k citations indexed

About

Meiqi Wang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Meiqi Wang has authored 90 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 27 papers in Oncology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Meiqi Wang's work include RNA modifications and cancer (9 papers), Pharmacological Effects of Natural Compounds (7 papers) and Drug Transport and Resistance Mechanisms (6 papers). Meiqi Wang is often cited by papers focused on RNA modifications and cancer (9 papers), Pharmacological Effects of Natural Compounds (7 papers) and Drug Transport and Resistance Mechanisms (6 papers). Meiqi Wang collaborates with scholars based in China, United States and Malaysia. Meiqi Wang's co-authors include Rui-Lin Zhao, Chaozhan Lin, Fangle Liu, Yingying Sun, Zhen‐Ni Guo, Chenchen Zhu, Hong-Jing Zhu, Yi Yang, Ruoyu Zhao and Shengyu Zhou and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Meiqi Wang

76 papers receiving 1.2k citations

Hit Papers

Remote ischemic conditioning attenuates oxidative stress ... 2023 2026 2024 2025 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meiqi Wang China 18 623 203 195 177 145 90 1.2k
Zeyao Tang China 21 681 1.1× 209 1.0× 118 0.6× 192 1.1× 121 0.8× 56 1.3k
Ju‐Hee Kang South Korea 23 800 1.3× 188 0.9× 133 0.7× 260 1.5× 124 0.9× 67 1.5k
Min Su China 22 703 1.1× 241 1.2× 95 0.5× 187 1.1× 114 0.8× 63 1.5k
Jiaqi Zhang China 22 752 1.2× 179 0.9× 102 0.5× 151 0.9× 162 1.1× 101 1.6k
Yingchun Zhou China 23 619 1.0× 155 0.8× 120 0.6× 136 0.8× 99 0.7× 67 1.2k
Yanjun Zheng China 23 803 1.3× 266 1.3× 171 0.9× 162 0.9× 244 1.7× 61 1.7k
Haihua Huang China 20 664 1.1× 194 1.0× 99 0.5× 174 1.0× 203 1.4× 61 1.4k
Zhongmei Wen China 17 708 1.1× 198 1.0× 152 0.8× 80 0.5× 104 0.7× 28 1.2k
Yong Jin China 23 720 1.2× 264 1.3× 92 0.5× 120 0.7× 251 1.7× 56 1.4k
Hong Luan China 20 528 0.8× 201 1.0× 93 0.5× 111 0.6× 116 0.8× 55 1.2k

Countries citing papers authored by Meiqi Wang

Since Specialization
Citations

This map shows the geographic impact of Meiqi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiqi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiqi Wang more than expected).

Fields of papers citing papers by Meiqi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meiqi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiqi Wang. The network helps show where Meiqi Wang may publish in the future.

Co-authorship network of co-authors of Meiqi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Meiqi Wang. A scholar is included among the top collaborators of Meiqi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meiqi Wang. Meiqi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Yang, Shuiqing, Wenbin Li, Chenshi Lin, et al.. (2025). Amylase-producing lung adenocarcinoma with an anaplastic lymphoma kinase fusion mutation: a case report. Laboratory Medicine. 56(6). 782–785.
4.
Wang, Meiqi, Magdolna Nagy, Victor Volovici, et al.. (2025). Microvascular Occlusion and Postrecanalization Hyperperfusion in a Swine Model of Acute Ischemic Stroke. Journal of the American Heart Association. 14(18). e042663–e042663.
5.
Liu, Fangle, et al.. (2025). Brunodelphinone and Brunodelphinine a, two novel C20-diterpenoid alkaloids isolated from Delphinium brunonianum Royle. Fitoterapia. 183. 106532–106532. 1 indexed citations
6.
Cui, Fang, Meiqi Wang, Jie Zhu, et al.. (2025). Biomimetic selenium nanomedicine with homologous targeting enhances hepatocellular carcinoma therapy. Materials Today Bio. 35. 102441–102441. 1 indexed citations
9.
Liu, Fangle, et al.. (2024). Trichodelphinine A alleviates pulmonary fibrosis by inhibiting collagen synthesis via NOX4-ARG1/TGF-β signaling pathway. Phytomedicine. 132. 155755–155755. 11 indexed citations
10.
Wang, Jin, Qiaoling Yuan, Meiqi Wang, et al.. (2024). The transcription factor CaBBX10 promotes chlorophyll and carotenoid pigment accumulation in Capsicum annuum fruit. PLANT PHYSIOLOGY. 197(2).
11.
Huang, Yunfei, Chunxiao Li, Lei Liu, et al.. (2024). The Survival Benefit of Pegylated Liposomal Doxorubicin-Based Neoadjuvant Chemotherapy in the Management of Breast Cancer. Cancer Biotherapy and Radiopharmaceuticals. 1 indexed citations
14.
Ren, Shengnan, Yongli Dong, Weidong Ni, et al.. (2023). Protamine 1 as a secreted colorectal cancer-specific antigen facilitating G1/S phase transition under nutrient stress conditions. Cellular Oncology. 46(2). 357–373. 1 indexed citations
15.
Chen, Simin, Meiqi Wang, Huanhuan Ma, et al.. (2023). β-Carboline alkaloids from Picrasma quassioides and their 3D-QSAR study on anti-inflammation in LPS-induced RAW 264.7 cells. Fitoterapia. 166. 105437–105437. 2 indexed citations
16.
Wang, Meiqi, Zhuo Liu, Xuedong Fang, Xianling Cong, & Yue Hu. (2023). The emerging role of m6A modification of non-coding RNA in gastrointestinal cancers: a comprehensive review. Frontiers in Cell and Developmental Biology. 11. 1264552–1264552. 2 indexed citations
17.
Wang, Shuqing, Meiqi Wang, Yue Cheng, et al.. (2022). Molecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae in a Tertiary Hospital in Northern China. Canadian Journal of Infectious Diseases and Medical Microbiology. 2022. 1–11. 3 indexed citations
18.
Zhou, Junliang, Mingyan Zhang, Meiqi Wang, et al.. (2021). Comprehensive Analysis of Acetylation-Related lncRNAs and Identified AC099850.3 as Prognostic Biomarker in Non-Small Cell Lung Cancer. Journal of Oncology. 2021. 1–19. 17 indexed citations
19.
Wang, Meiqi, Mingyan Zhang, & Hui Xu. (2020). First report of bacteremia caused by Eggerthia catenaformis in a patient with gastric malignancy in China. Anaerobe. 64. 102218–102218. 7 indexed citations
20.
Li, Shujun, et al.. (1978). Studies on Structure and Function of Chloroplasts II. Isolation and Interchangeability of Pure Chloroplast Coupling Factors. Journal of Integrative Plant Biology. 20(2). 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026